Superseded · version 1: Elamipretide^↗

Related names recorded in this version: SS-31, MTP-131^↗

A mitochondria-targeting peptide candidate represented in ClinicalTrials.gov.^↗

This is preserved historical wording.
It is no longer the current profile. Read the current profile and its correction notice.

What this version reported

ClinicalTrials.gov lists the 4TAZPower study as recruiting, updated July 13, 2026.^↗

Organizations named in cited records:

Trial records: NCT07531251